The Carlyle Group Inc. is a global investment management firm founded in 1987 that deploys private capital across three business segments: Global Private Equity, Global Credit, and Carlyle AlpInvest. The Global Private Equity segment advises buyout, growth, real estate, infrastructure, and natural resources funds, with strategic investments in NGP for North American energy. The Global Credit segment offers liquid credit, direct lending, asset-backed finance, and insurance solutions, including the Carlyle Insurance Solutions platform and strategic advisory services for Fortitude. Carlyle AlpInvest provides secondary and portfolio finance opportunities. The firm serves institutional investors, financial advisors, and portfolio companies across four continents, managing assets through diverse strategies in corporate private equity, real estate, infrastructure, and credit markets.

Summarised from the company's own disclosures, fiscal year ended Feb 2026

Industry Asset Management Homepage carlyle.com
Sector Financial Services IR page carlyle.com/institutional-investors
Tags
private equity, global credit, real estate, infrastructure, direct lending, insurance solutions, secondaries, natural resources, buyout funds, growth capital, Global Private Equity, Carlyle AlpInvest, NGP, Carlyle Insurance Solutions, Fortitude, FCA Re, CRP X, CAP VI, CPI, Orion Breweries, Hexaware, Medline
Press page carlyle.com/news-media

Metrics

Valuation  
Market cap $ 14.028B
Market cap (USD) $ 14.028B
P/E 42.19
PEG —
P/BV 2.13
P/S 3.88
P/OCF -6.75
P/FCF -6.36
Dividend yield 3.5%
Turnover / mcap —
Returns  
ROE 12.1%
ROI 4.7%
ROIC 4.7%
Profit margin 16.9%
Growth  
Revenue growing No
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) -12.9%
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 35
Quality score -31.6%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011
Revenue 4.78B 5.426B 2.964B 4.439B 8.782B 2.935B 3.377B 2.427B 3.676B 2.274B 3.006B 3.88B 4.441B 2.973B 2.845B
Net profit 808.7M 1.02B -608.4M 1.225B 2.975B 348.2M 380.9M 116.5M 244.1M 6.4M -18.4M 85.8M 104.1M 20.3M 1.154B
Free cash flow -3.375B -837.2M 138.3M -419.9M 1.75B -230.4M 330.8M -374.8M -41.1M -326M 3.841B 2.616B 2.965B 1.996B 2.644B

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011
Share price 59.11 50.49 40.69 29.84 54.9 31.44 32.08 15.75 22.9 16.13 17.77 32.55 26.88 — —
Price performance 12m 0.17 0.24 0.36 -0.46 0.75 -0.02 1.04 -0.31 0.42 -0.09 -0.45 0.21 — — —

Filed figures

Figure Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Borrowings, non-current (USD) 1.27B 1.57B 1.55B 1.98B 1.97B 2.07B 2.27B — — —
Lease liabilities (USD) — — 0.00 288M 514M 538M 503M 488M 489M 470M
Cash and deposits (USD) 671M 1B 630M 793M 988M 2.47B 1.36B 1.44B 1.27B 1.97B
Intangible assets (USD) 31.9M 24.8M 62M 46.2M 31.9M 21.6M 794M 662M 531M 403M
Right-of-use assets (USD) — — 0.00 204M 361M 361M 337M 332M 341M 332M
Net debt (borrowings + leases - cash) (USD) 594M 574M 921M 1.47B 1.5B 140M 1.41B — — —
Cash flow detail
Operating cash flow (USD) -301M -7.1M -344M 359M -169M 1.79B -379M 205M -760M -3.28B
Purchases of property, plant and equipment (USD) -25.4M -34M -31.3M -27.8M -61.2M -41.4M -40.6M -66.6M -77.7M -99.4M
Change in payables (cash effect) (USD) 66.6M 50.5M 78.2M -43.7M -4M 106M -14.3M -33.2M 58.8M 150M
Dividends paid (cash effect) (USD) -141M -118M -130M -155M -351M -356M -444M -498M -503M -505M
Share buybacks (cash effect) (USD) -58.9M -200,000 -108M -34.5M -26.4M -162M -186M -204M -555M -687M
Interest paid (cash effect) (USD) -59M -59.5M -60.7M -63.4M -80.1M -92.7M -91.5M -91.8M -93.6M -91.7M
Income taxes paid (cash effect) (USD) -35.1M -24.8M -28.9M -30.5M -35.4M -403M -402M -250M -219M -153M
Share-based compensation (USD) 335M 320M 240M 140M 105M 163M 154M 249M 468M 375M
Free cash flow (OCF - PPE - intangibles) (USD) -326M -41.1M -375M 331M -230M 1.75B -420M 138M -837M -3.37B
Income detail
Total comprehensive income (USD) -44.2M 1.1B 283M 1.21B 405M 3B 1.19B -459M 1.05B 1.12B
Comprehensive income to owners (USD) 5.8M 261M 111M 384M 368M 2.94B 1.15B -584M 988M 968M
Reported May 3, 2017 May 1, 2018 May 1, 2019 Apr 30, 2020 Apr 29, 2021 Apr 28, 2022 May 4, 2023 Feb 22, 2024 Feb 27, 2025 Feb 27, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Carlyle Reports Third Quarter 2026 Financial Results Bull 0 Bear 0 Results

Washington, D.C. and New York, NY – November 5, 2026 – The Carlyle Group Inc. (NASDAQ: CG) today reported its unaudited results for the third quarter ended September 30, 2026. The full detailed presentation of Carlyle’s third quarter 2026 results can be viewed at ir.carlyle.com.

U.S. GAAP results for Q3 2026 included loss before provision for income taxes of $77 million and a margin on loss before provision for income taxes of 23.0%.

Carlyle Chief Executive Officer Harvey M. Schwartz said, “Our third quarter results reflect the strength of Carlyle’s diversified global platform and the significant momentum we continue to build across the firm. We delivered one of our strongest quarters of Distributable Earnings per share on record, while distinguishing ourselves as an outlier in returning capital to our investors, approaching $100 billion in distributions since the beginning of 2024. With near-record levels of Pending Fee-earning AUM and the early stages of a powerful fundraising super-cycle, we are exceptionally well positioned to accelerate growth in the years ahead.”

Dividend

The Board of Directors has declared a quarterly dividend of $0.35 per common share to holders of record at the close of business on November 16, 2026, payable on November 23, 2026. 

Conference Call

Carlyle will host a conference call at 8:30 a.m. EST on Thursday, November 5, 2026, to discuss its third quarter 2026 financial results. The conference call will be available via public webcast from the Events & Presentations section of ir.carlyle.com and a replay will also be available on our website soon after the call’s completion.

About Carlyle

Carlyle (NASDAQ: CG) is a global investment firm with deep industry expertise that deploys private capital across three business segments: Global Private Equity, Global Credit, and Carlyle AlpInvest. With $479 billion of assets under management as of September 30, 2026, Carlyle’s purpose is to connect people, ideas, and capital to fuel growth for companies and performance for investors. Carlyle employs more than 2,600 people in 28 offices across four continents. Further information is available at www.carlyle.com . Follow Carlyle on X @OneCarlyle and LinkedIn at The Carlyle Group.

Forward-Looking Statements

This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include, but are not limited to, statements related to our expectations, estimates, beliefs, projections, future plans and strategies, anticipated events or trends, and similar expressions and statements that are not historical facts, including our expectations regarding the performance of our business, our financial results, our liquidity and capital resources, contingencies, and our dividend policy. You can identify these forward-looking statements by the use of words such as “outlook,” “believes,” “expects,” “potential,” “continues,” “may,” “will,” “should,” “seeks,” “approximately,” “predicts,” “intends,” “plans,” “estimates,” “anticipates,” or the negative version of these words or other comparable words. Such forward-looking statements are subject to various risks, uncertainties, and assumptions. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements including, but not limited to, those described in this press release and under the section entitled “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025, filed with the U.S. Securities and Exchange Commission (“SEC”) on February 27, 2026, as such factors may be updated from time to time in our periodic filings with the SEC, which are accessible on the SEC’s website at www.sec.gov . These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this press release and in our other periodic filings with the SEC. We undertake no obligation to publicly update or review any forward-looking statements, whether as a result of new information, future developments, or otherwise, except as required by applicable law.

This press release does not constitute an offer for any Carlyle fund.

London, UK – 3 November 2026 - PAI Partners and Carlyle (NASDAQ: CG) today announced an agreement to sell Theramex, a leading global specialty pharmaceutical company focused on women’s health, to Cinven. The transaction is subject to customary regulatory approvals and is expected to close in the first half of 2027. The financial terms of the transaction are not being disclosed.

Headquartered in London, Theramex offers a diversified portfolio of treatments across menopause, osteoporosis, contraception, uterine health and fertility. The company has established a significant international presence, reaching more than six million patients in over 80 countries in Europe, Africa, Asia-Pacific and Latin America. 

Since their acquisition of the business in 2022, Carlyle and PAI have worked closely with Theramex’s management team to accelerate the company’s growth, expand and diversify its portfolio of established and innovative treatments across existing and adjacent therapeutic areas. During their ownership, Theramex has more than doubled its EBITDA, supported by the successful launch and scale-up of new treatments, as well as strategic acquisitions and in-licensing agreements. 

In addition, PAI and Carlyle supported the expansion of Theramex’s commercial infrastructure across 17 direct markets, strengthened its operating model and supply chain, and invested in talent and leadership to drive the company’s long-term growth. Collectively, these efforts helped raise awareness of women's health and improve access to treatments across the markets where Theramex operates.

Robert Stewart, CEO of Theramex said: “This is a proud moment for everyone at Theramex. I thank our talented team, and Carlyle and PAI for their outstanding partnership, which helped us more than double the business and transform the company. With Cinven, we have the right partner for our next chapter, and we share an ambition to become the global leader in women's health." 

Lubna Qunash, a Partner on the Carlyle Europe Partners investment advisory team, said: “Women’s health remains an area of significant unmet medical need, and Theramex plays an important role in improving access to innovative treatments. Together with PAI and Theramex’s management team, we have expanded Theramex’s portfolio, launched new therapies and strengthened its international presence, positioning the business for continued growth. We would like to express our sincere gratitude to Rob and his team for their exceptional dedication, leadership and contributions. Their commitment has been instrumental to the company’s success, and we wish them every success in their next chapter.”

Sébastien Veil and Benoît Bousquié, Partners at PAI, said: “Theramex has undergone a significant transformation over the past four years and is now a stronger, more diversified international business dedicated to women’s health. We are proud to have supported its growth, helping to broaden its portfolio of treatments while raising awareness of women’s health. We thank the Theramex team and Carlyle for their commitment and partnership, and wish the business continued success in the years ahead.” 

--

About Theramex

Theramex is a leading global specialty pharmaceutical company focused on women’s health. The company offers a broad portfolio of products across menopause, osteoporosis, contraception, uterine health and fertility. Headquartered in London, Theramex operates in more than 80 countries through a combination of direct presence and trusted partners.

About PAI Partners

PAI Partners is a pre-eminent private equity firm investing in market-leading companies across the globe. The Firm has c. €25 billion of assets under management and, since 1994, has completed over 100 investments in 13 countries and realised more than €33 billion in proceeds from c. 70 exits. PAI has built an outstanding track record through partnering with ambitious management teams, where its unique perspective, unrivalled sector experience and long-term vision enable companies to pursue their full potential – and push beyond. Learn more at www.paipartners.com  

About Carlyle

Carlyle (NASDAQ: CG) is a global investment firm with deep industry expertise that deploys private capital across three business segments: Global Private Equity, Global Credit and Carlyle AlpInvest. With $485 billion of assets under management as of June 30, 2026, Carlyle’s purpose is to connect people, ideas and capital to fuel growth for companies and performance for investors. Carlyle employs more than 2,500 people in 28 offices across four continents. Further information is available at www.carlyle.com . Follow Carlyle on X at @OneCarlyle and LinkedIn at The Carlyle Group.

Media Contacts

Theramex
Monika Sivilli
[email protected]  
+44 7340 747830

Carlyle
Alexander Hockaday
[email protected]  
+44 7407 853 818

PAI Partners
Dania Saidam
[email protected]  
+44 20 7297 4678
 

Carlyle

Subscribe to Our Newsletters

Subscribe to our newsletter to stay in the loop.

Sign up

Footer Menu

Footer Bottom Menu

NEW YORK, NY and SALT LAKE CITY, UT – November 2, 2026 – Global investment firm Carlyle (NASDAQ: CG) and Kingbee Vans ("Kingbee"), a leading provider of flexible fleet rental solutions, today announced a $225 million asset-backed financing agreement to support the expansion of Kingbee's commercial vehicle fleet.

Under the agreement, Carlyle's Global Credit platform will provide a senior secured financing facility to support Kingbee's acquisition of new cargo vans for rental to commercial fleet operators across the United States. The transaction represents a customized asset-backed financing solution designed to provide Kingbee with institutional capital, scale and expertise as it expands its fleet to meet growing customer demand.

Founded in 2021 and headquartered in Salt Lake City, Utah, Kingbee provides work-ready commercial vehicles to customers across last-mile delivery, logistics and commercial services. The company combines vehicle sourcing, customization, rental and fleet management services to help businesses access commercial vehicles without the capital requirements and operational complexities of direct ownership.

The transaction underscores Carlyle's focus on investing behind logistics and fleet assets supported by underlying supply-demand dynamics. As consumer preferences continue to shift toward home delivery of goods, groceries and other everyday essentials, commercial vehicle fleets are playing an increasingly important role in supporting the broader delivery and logistics ecosystem. 

“Last-mile delivery keeps rising while new cargo-van supply remains tight,” said Eldar Ben-Zikry, Principal at Carlyle. “Kingbee has built a platform that helps address that gap by sourcing, upfitting, and renting work-ready vans at scale, and we’re pleased to support its next phase of growth.”

"This is the kind of financing Carlyle ABF is built to provide,” said Akhil Bansal, Head of Asset-Backed Finance at Carlyle. “We’re backing Kingbee with capital secured by hard assets and contracted rental cash flows, structured for a company whose growth requires a scaled capital partner."

“Partnering with Carlyle marks a major step forward in Kingbee’s long-term growth strategy,” said Scott Haslam, Founder & CEO of Kingbee Vans. “As the commercial fleet industry continues to expand, this financing will play a key role in accelerating our fleet growth, expanding our nationwide network of hubs, and strengthening our ability to scale operations to meet the growing demand for flexible fleet solutions.”

This investment is being led by Carlyle’s Asset-Backed Finance (“ABF”) team within the firm’s Global Credit platform. Carlyle ABF invests across private fixed income and asset-backed assets, providing financing solutions to and acquiring portfolios of financial assets from businesses, specialty finance companies, and asset owners. As of June 30, 2026, Carlyle’s Global Credit platform had approximately $211 billion in assets under management.

Paul Hastings LLP acted as legal advisor to Carlyle on the transaction. 

About Carlyle 
Carlyle (NASDAQ: CG) is a global investment firm with deep industry expertise that deploys private capital across three business segments: Global Private Equity, Global Credit and Carlyle AlpInvest. With $485 billion of assets under management as of June 30, 2026, Carlyle’s purpose is to connect people, ideas and capital to fuel growth for companies and performance for investors. Carlyle employs more than 2,500 people in 28 offices across four continents. Further information is available at www.carlyle.com. Follow Carlyle on X at @OneCarlyle and LinkedIn at The Carlyle Group.

Media Contacts

For Carlyle

Max Berger
917-533-4374
[email protected]  

For Kingbee

Lily Weickum 
(828) 546-4233
[email protected]  

Carlyle

Subscribe to Our Newsletters

Subscribe to our newsletter to stay in the loop.

Sign up

Footer Menu

Footer Bottom Menu

Prompts

The Carlyle Group Inc. (ticker CG), listed in United States.

ETFs Holding The Carlyle Group Inc.

ETF Weight in ETF Shares Market value As of
LBO 3.94% 6,356 $ 240K Nov 18, 2026
LBAY short -1.52% -6,851 $ -264.586K Nov 17, 2026
CBLS short -1.04% -12,600 $ -579.852K Jul 31, 2026
WTV 0.47% 330,041 $ 13.898M Jun 30, 2026
CLSE short -0.37% -68,575 $ -3.318M Aug 31, 2026
BTAL short -0.35% -23,276 $ -980.152K Jun 30, 2026
JHPI 0.21% 26,088 $ 425.495K Jun 30, 2026
BDVL short -0.19% -87,430 $ -3.377M Nov 16, 2026
PHEQ 0.14% 4,817 $ 202.844K Jun 30, 2026
JMEE 0.12% 87,923 $ 3.359M Nov 17, 2026
AVMC 0.10% 14,925 $ 576.404K Nov 16, 2026
MSSM 0.10% 14,507 $ 701.994K Aug 31, 2026
LCTU 0.08% 24,677 $ 953.026K Nov 16, 2026
VFVA 0.07% 13,310 $ 644.071K Aug 31, 2026
AVSU 0.05% 6,485 $ 250.451K Nov 16, 2026
DFVX 0.04% 6,564 $ 258.359K Nov 12, 2026
PEPS 0.04% 277 $ 11.664K Jun 30, 2026
DFSU 0.04% 23,881 $ 939.956K Nov 12, 2026
DFAC 0.03% 766,151 $ 30.156M Nov 12, 2026
DXUV 0.03% 49,625 $ 1.953M Nov 12, 2026
IALT short -0.03% -64,342 $ -2.485M Nov 16, 2026
AVLC 0.03% 10,504 $ 405.664K Nov 16, 2026
MODL 0.03% 6,659 $ 280.41K Jun 30, 2026
DCOR 0.03% 311,890 $ 12.276M Nov 12, 2026
DFUV 0.03% 102,882 $ 4.049M Nov 12, 2026
DFAU 0.02% 81,205 $ 3.196M Nov 12, 2026
NTSX 0.02% 7,186 $ 302.602K Jun 30, 2026
GDE 0.02% 2,016 $ 97.554K Aug 31, 2026
AVUS 0.02% 72,230 $ 2.79M Nov 16, 2026
DFLV 0.02% 35,236 $ 1.387M Nov 12, 2026
DFUS 0.01% 77,635 $ 3.056M Nov 12, 2026
MSLC 0.01% 9,981 $ 482.981K Aug 31, 2026
DFAS 0.01% 73,346 $ 2.887M Nov 12, 2026
NTSD 0.01% 44 $ 1,852.84 Jun 30, 2026
EBI 0.00% 698 $ 33.776K Aug 31, 2026

Securities

Ticker Type Class Market Exchange Last price Price date
CG canonical Common share — US nasdaq 39.66 USD 2026-09-30
CGABL Bond — US nasdaq — —